| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 144.59× | 144.59× | 147.23× | 143.21× | 147.90× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.12× | 2.32× | 2.48× | 5.29× | 2.05× | ||
| 0.27× | 0.27× | 0.27× | 0.28× | 0.27× | ||
| 7.92× | 7.92× | 4.93× | 5.38× | 5.99× | ||
| 0.86× | 0.86× | 1.07× | 1.21× | 1.44× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 147.90 | 143.21 | 147.23 | 144.59 | 144.59 | |
| Working Capital Turnover | 2.05 | 5.29 | 2.48 | 2.32 | 2.12 | |
| Asset Turnover | 0.27 | 0.28 | 0.27 | 0.27 | 0.27 | |
| Cash Conversion (CFO/Net Income) | 5.99 | 5.38 | 4.93 | 7.92 | 7.92 | |
| CFO/EBITDA | 1.44 | 1.21 | 1.07 | 0.86 | 0.86 |